HK1069771A1 - Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis - Google Patents
Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosisInfo
- Publication number
- HK1069771A1 HK1069771A1 HK05102272.0A HK05102272A HK1069771A1 HK 1069771 A1 HK1069771 A1 HK 1069771A1 HK 05102272 A HK05102272 A HK 05102272A HK 1069771 A1 HK1069771 A1 HK 1069771A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- phenoxy
- osteoporosis
- thiazolyl
- alkoxy
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0043490A KR100454767B1 (ko) | 2001-07-19 | 2001-07-19 | 4-[(4-티아졸릴)페녹시]알콕시-벤즈아미딘 유도체의골다공증 예방 및 치료제로서의 용도 |
PCT/KR2002/000463 WO2003007947A1 (en) | 2001-07-19 | 2002-03-19 | Use of 4-[(4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1069771A1 true HK1069771A1 (en) | 2005-06-03 |
Family
ID=19712300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05102272.0A HK1069771A1 (en) | 2001-07-19 | 2005-03-15 | Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis |
Country Status (14)
Country | Link |
---|---|
US (2) | US7662840B2 (xx) |
EP (1) | EP1411935B1 (xx) |
JP (1) | JP4047275B2 (xx) |
KR (1) | KR100454767B1 (xx) |
CN (1) | CN100435794C (xx) |
AT (1) | ATE468117T1 (xx) |
AU (1) | AU2002241361B2 (xx) |
BR (1) | BR0211329A (xx) |
CA (1) | CA2454022C (xx) |
DE (1) | DE60236438D1 (xx) |
ES (1) | ES2342155T3 (xx) |
HK (1) | HK1069771A1 (xx) |
WO (1) | WO2003007947A1 (xx) |
ZA (1) | ZA200400331B (xx) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8242152B2 (en) | 2001-07-19 | 2012-08-14 | Dong Wha Pharmaceutical Co., Ltd. | Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for the prophylaxis and treatment of osteoporosis |
KR100454767B1 (ko) | 2001-07-19 | 2004-11-03 | 동화약품공업주식회사 | 4-[(4-티아졸릴)페녹시]알콕시-벤즈아미딘 유도체의골다공증 예방 및 치료제로서의 용도 |
EP1773794A4 (en) * | 2004-07-05 | 2009-09-09 | Dong Wha Pharm Ind Co Ltd | IMPROVED METHOD FOR PREPARING N-HYDROXY-4 {5- [4- (5-ISOPROPYL-2-METHYL-1,3-THIAZOL-4-YL) -PHENOXY] -PENTOXY} -BENZAMIDINE |
CA2572897C (en) * | 2004-07-05 | 2010-08-24 | Dong Wha Pharmaceutical Ind. Co., Ltd. | Pharmaceutical composition for the treatment of bone fracture |
JP4657297B2 (ja) * | 2004-07-05 | 2011-03-23 | ドン ファ ファーマシューティカル カンパニー リミテッド | アレルギー性炎症疾患の予防及び治療用組成物 |
KR20060017929A (ko) * | 2004-08-04 | 2006-02-28 | 동화약품공업주식회사 | 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물 |
EP1701722B1 (en) * | 2004-11-23 | 2009-10-14 | Dong Wha Pharmaceutical Co., Ltd. | N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy¨]pentoxy}benzamidine 2 methansulfonic acid salt |
CN101351707B (zh) * | 2005-12-28 | 2014-03-26 | 积水医疗株式会社 | 凝集测量用试剂以及凝集测量方法 |
WO2007089101A1 (en) | 2006-01-31 | 2007-08-09 | Dong Wha Pharmaceutical Ind.Co., Ltd. | Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same |
EP2146974B1 (en) * | 2007-04-19 | 2011-01-05 | Dong Wha Pharmaceutical Co., Ltd. | N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same |
AU2008283211B2 (en) * | 2007-07-27 | 2011-04-07 | Dong Wha Pharmaceutical Co., Ltd. | Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same |
CA2694638A1 (en) * | 2007-08-02 | 2009-02-05 | Teijin Pharma Limited | Preventive or therapeutic agent for diseases caused by abnormal bone metbolism |
US7964584B2 (en) | 2008-08-01 | 2011-06-21 | Dong Wha Pharmaceutical Co., Ltd. | Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt |
KR20100014090A (ko) * | 2008-08-01 | 2010-02-10 | 동화약품주식회사 | 벤즈아미딘 유도체 또는 이의 염, 및 비스포스포네이트를 포함하는 골다공증의 예방 또는 치료용 약학 조성물 |
EP2307015A4 (en) * | 2008-08-01 | 2012-05-16 | Dong Wha Pharm Co Ltd | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS BASED ON DERIVATIVES OF BENZAMIDINE OR SALTS THEREOF, AND ALENDRONIC ACID OR SALTS THEREOF |
WO2010087517A1 (ja) | 2009-01-30 | 2010-08-05 | 帝人ファーマ株式会社 | 骨代謝異常に起因する疾患の予防剤又は治療剤 |
EP3383868B1 (en) | 2015-11-30 | 2022-10-05 | Merck Sharp & Dohme LLC | Aryl sulfonamides as blt1 antagonists |
WO2017095725A1 (en) | 2015-11-30 | 2017-06-08 | Merck Sharp & Dohme Corp. | Aryl sulfonamides as blt1 antagonists |
EP3383388B1 (en) | 2015-11-30 | 2021-04-14 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
US10370368B2 (en) | 2015-11-30 | 2019-08-06 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as BLT1 antagonists |
JP7373191B2 (ja) | 2017-05-12 | 2023-11-02 | 国立研究開発法人理化学研究所 | クラスa gpcr結合性化合物改変体 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5488160A (en) * | 1991-06-11 | 1996-01-30 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and method of treatment |
EP0518818A3 (en) * | 1991-06-11 | 1993-04-28 | Ciba-Geigy Ag | Arylethers, their manufacture and use as medicament |
US5451700A (en) | 1991-06-11 | 1995-09-19 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and methods of treatment |
US5521315A (en) * | 1993-01-12 | 1996-05-28 | Cell Therapeutics, Inc. | Olefin substituted long chain compounds |
WO1995032710A1 (en) * | 1994-05-27 | 1995-12-07 | Merck & Co., Inc. | Compounds for inhibiting osteoclast-mediated bone resorption |
CN1244196A (zh) | 1997-02-04 | 2000-02-09 | 同和药品工业株式会社 | 3-氨基-1,2-苯并异噁唑衍生物,其制备方法和应用 |
US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6124314A (en) * | 1997-10-10 | 2000-09-26 | Pfizer Inc. | Osteoporosis compounds |
KR100454767B1 (ko) | 2001-07-19 | 2004-11-03 | 동화약품공업주식회사 | 4-[(4-티아졸릴)페녹시]알콕시-벤즈아미딘 유도체의골다공증 예방 및 치료제로서의 용도 |
-
2001
- 2001-07-19 KR KR10-2001-0043490A patent/KR100454767B1/ko active IP Right Grant
-
2002
- 2002-03-19 WO PCT/KR2002/000463 patent/WO2003007947A1/en active Application Filing
- 2002-03-19 BR BR0211329-5A patent/BR0211329A/pt not_active Application Discontinuation
- 2002-03-19 CN CNB02814497XA patent/CN100435794C/zh not_active Expired - Lifetime
- 2002-03-19 AU AU2002241361A patent/AU2002241361B2/en not_active Expired
- 2002-03-19 ES ES02707300T patent/ES2342155T3/es not_active Expired - Lifetime
- 2002-03-19 AT AT02707300T patent/ATE468117T1/de not_active IP Right Cessation
- 2002-03-19 DE DE60236438T patent/DE60236438D1/de not_active Expired - Lifetime
- 2002-03-19 JP JP2003513555A patent/JP4047275B2/ja not_active Expired - Lifetime
- 2002-03-19 CA CA002454022A patent/CA2454022C/en not_active Expired - Lifetime
- 2002-03-19 US US10/484,094 patent/US7662840B2/en not_active Expired - Lifetime
- 2002-03-19 EP EP02707300A patent/EP1411935B1/en not_active Expired - Lifetime
-
2004
- 2004-01-15 ZA ZA2004/00331A patent/ZA200400331B/en unknown
-
2005
- 2005-03-15 HK HK05102272.0A patent/HK1069771A1/xx not_active IP Right Cessation
-
2010
- 2010-01-19 US US12/689,878 patent/US8227496B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2004537549A (ja) | 2004-12-16 |
CA2454022C (en) | 2009-10-13 |
DE60236438D1 (de) | 2010-07-01 |
EP1411935A4 (en) | 2005-11-09 |
JP4047275B2 (ja) | 2008-02-13 |
ZA200400331B (en) | 2005-06-29 |
US20100120875A1 (en) | 2010-05-13 |
CN1533275A (zh) | 2004-09-29 |
BR0211329A (pt) | 2004-09-28 |
KR100454767B1 (ko) | 2004-11-03 |
US7662840B2 (en) | 2010-02-16 |
CN100435794C (zh) | 2008-11-26 |
US8227496B2 (en) | 2012-07-24 |
US20040186150A1 (en) | 2004-09-23 |
KR20030008654A (ko) | 2003-01-29 |
ATE468117T1 (de) | 2010-06-15 |
EP1411935A1 (en) | 2004-04-28 |
CA2454022A1 (en) | 2003-01-30 |
AU2002241361B2 (en) | 2007-01-25 |
WO2003007947A1 (en) | 2003-01-30 |
EP1411935B1 (en) | 2010-05-19 |
ES2342155T3 (es) | 2010-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1069771A1 (en) | Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis | |
TW200420549A (en) | Thiazole derivatives | |
WO2006011631A3 (en) | Thiazole derivatives having vap-1 inhibitory activity | |
KR940019699A (ko) | 옥사졸리딘디온 유도체, 그의 제조방법 및 용도 | |
SG156517A1 (en) | Methods and compositions for treating hepatitis c virus | |
WO2001081312A3 (en) | Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore | |
MXPA02011641A (es) | Metodos para tatar infecciones por viurs de hepatitis delta con beta-l-2'-desoxi-nucleosidos. | |
AU2483000A (en) | Treatment of asthma with mek inhibitors | |
BG106287A (en) | Respiratory syncytial virus replication inhibitors | |
ATE369845T1 (de) | Behandlung der nebenwirkungen von statinen | |
MY150903A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain | |
GB0024361D0 (en) | Medicaments | |
AP1441A (en) | Hydrate of 5- [4-{2-(N-methlyl-N-(2-pyridil) amino) ethoxy} benzyl] thiazolidine-2,4-dione maleic acid salt. | |
CA2473202A1 (en) | Pharmaceutical composition for regeneration of cirrhotic liver | |
CA2572897A1 (en) | Pharmaceutical composition for the treatment of bone fracture | |
UY26112A1 (es) | Dihidrato de hidrocloruro de 5- [4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona | |
HUP0202836A2 (hu) | Piridazinonszármazék új alkalmazása | |
RU96120159A (ru) | Производные тиазолидиндиона в качестве противогипергликемических средств | |
MXPA04003631A (es) | Rosuvastatina en estados de pre-demencia. | |
KR970701704A (ko) | 항과혈당제로서의 티아졸리딘디온 유도체(Thiazolidinedione derivatives as antihyperglycemic agents) | |
PT1446404E (pt) | Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos | |
NZ337927A (en) | Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds | |
EP2146974A4 (en) | SALT OF N-HYDROXY-4- {5- [4- (5-ISOPROPYL-2-METHYL-1,3-THIAZOL-4-YL) PHENOXY] PENTOXY} BENZAMIDINE 2-ETHANESULPHONIC ACID, ITS PREPARATION METHOD AND COMPOSITION PHARMACEUTICAL COMPRISING IT | |
AP2002002673A0 (en) | Thiazolidinedione salt for the treatment of diabetes mellitus. | |
WO2007146039A3 (en) | Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20220318 |